At the IGTP TODAY
On 7 February, "#100tífiques" returned for its sixth edition, a macro-event that has become a benchmark for advocacy within the Catalan female research community and schools. Expanding on last year's participant numbers, thirteen scientists from IGTP took part in this event.
An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood. This is a significant advance in the understanding of how the immune system can prevent the appearance of tumours.
Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.
In 2023, the IGTP has continued to make significant strides in its mission. Here, we review the year's top news stories, reflecting the persistent drive and collaborative spirit that underpin this institution.
The funds raised in the 2022 edition of La Marató de 3Cat will enable 71 research teams to conduct 37 projects in cardiovascular health to advance in the prevention, diagnosis, and treatment of diseases that represent the leading cause of death in developed countries. One of the awarded projects involves the participation of researchers from the GCAT of the IGTP, and is coordinated by Dr Camille Lassale from ISGlobal.
The third General Assembly of the END-VOC Consortium took place on 7 and 8 June hosted by the Barcelona Institute for Global Health (ISGlobal). Germans Trias i Pujol Research Institute (IGTP), who is leading the GCAT project and collaborating in several of the project's work packages, was one of the partners who participated in this meeting attended by more than 50 consortium members.
The COVICAT-CONTENT 2023 study begins today, with the aim of monitoring COVID-19 in different cohorts in Catalonia and the rest of Spain. Researchers from the Barcelona Institute for Global Health (ISGlobal) and the GCAT'Genomes for Life project of the Germans Trias i Pujol Research Institute (IGTP) evaluate the genetic and epidemiological determinants associated with the disease, as well as the long-term effects of the pandemic on people's physical and mental health and the evolution of the immune response. In this way, the objective is to help define predictive models and control policies for similar situations in the future.
Researchers from the GCAT|Genomes for Life project of the IGTP have analysed the genetic basis of 13 pigment traits and their association with diseases. The work has been published this month in Genes.
The Severe Covid-19 GWAS Group, the group that reported the first genetic analysis in early pandemic (NEJM, 2020), presents now the new results of an extended GWAS meta-analysis of a well-characterized cohort of 3,260 COVID-19 patients with respiratory failure and 12,483 population controls from Italy, Spain, Norway and Germany/Austria, that have been published in Human Molecular Genetics.
On 20 June the Germans Trias i Pujol Research Institute (IGTP) celebrated the GCAT|Genomes for Life Community Symposium at the Badalona International Business Center (BCIN). GCAT is a strategic project of IGTP and the meeting, this year by invitation-only format, included national experts in the fields of genomics and precision medicine to discuss the status of prospective cohorts in Spain in general and to showcase the current research being generated by the GCAT cohort in particular.
